Printer Friendly

PFIZER APPOINTS KAREN L. KATEN EXECUTIVE VICE PRESIDENT OF U.S. PHARMACEUTICALS GROUP

 NEW YORK, May 10 /PRNewswire/ -- Karen L. Katen has been promoted to executive vice president of Pfizer's U.S. Pharmaceuticals Group, Edward C. Bessey, vice chairman of Pfizer Inc, announced today. Ms. Katen will be responsible for all sales and marketing divisions, which encompass Roerig, Pfizer Labs, Pratt Pharmaceuticals and National Healthcare Operations.
 Ms. Katen, who had been vice president and general manager of the Roerig Division, will report to Mr. Bessey, who also serves as president of U.S. Pharmaceuticals.
 "Naming Karen Katen to this newly created position will allow us to enhance our ability to respond effectively to today's rapidly changing marketplace," Mr. Bessey said.
 Karen Katen joined Pfizer in 1974 as a management associate in Pharmaceuticals. In 1975 she began a series of promotions in the Roerig product management group, culminating as group product manager in 1978. In 1980, Ms. Katen became a group product manager in Pfizer Labs. She was named director of Product Management before returning to Roerig in 1983 as vice president-Marketing. In 1986 she was appointed vice president/director of operations for Roerig, and in 1991 became vice president/general manager. She was elected an officer of Pfizer Inc last year.
 Ms. Katen holds a B.A. in political science and economics as well as an M.B.A. in marketing and finance from the University of Chicago.
 Pfizer Inc is a research-based, diversified health-care company with global operations. The company reported sales of approximately $7.23 billion for 1992.
 -0- 5/10/93
 /CONTACT: A. A. Biesada, 212-573-2055, or Rick Honey, 212-573-2051, both for Pfizer/
 (PFE)


CO: Pfizer Inc ST: New York IN: MTC SU: PER

LR -- NY072 -- 6551 05/10/93 14:19 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 10, 1993
Words:283
Previous Article:EDS PURCHASES BEI GOLEMBE
Next Article:ASTROTECH INTERNATIONAL CORPORATION
Topics:


Related Articles
PFIZER NAMES BESSEY HEAD OF U.S. PHARMACEUTICALS; MCKINNELL BECOMES PRESIDENT OF HOSPITAL PRODUCTS
PFIZER ANNOUNCES EXECUTIVE APPOINTMENTS.
ARMOUR PHARMACEUTICAL COMPANY APPOINTS TWO NEW EXECUTIVES
PFIZER NAMES B.J. ROBISON PRESIDENT, CONSUMER HEALTH CARE
PFIZER NAMES B.J. ROBISON PRESIDENT, CONSUMER HEALTH CARE
BARRY BLOOM TO RETIRE FROM PFIZER; JOHN NIBLACK NAMED EXECUTIVE VICE PRESIDENT -- R&D
PFIZER ANNOUNCES NEW EXECUTIVE RESPONSIBILITIES; TOMBROS MOVES TO V.P. FOR INVESTOR RELATIONS, SCHULZE NAMED V.P. FOR CORPORATE STRATEGIC PLANNING,...
PFIZER BOARD ELECTS TWO CORPORATE OFFICERS
EDWARD C. BESSEY TO RETIRE AS VICE CHAIRMAN OF PFIZER AND PRESIDENT OF ITS U.S. PHARMACEUTICALS GROUP

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters